Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Rectal Neoplasms 29Esophageal Neoplasms 18Squamous Cell Carcinoma of Head and Neck 15Carcinoma, Non-Small-Cell Lung 14Nasopharyngeal Carcinoma 12Uterine Cervical Neoplasms 11Head and Neck Neoplasms 11Pancreatic Neoplasms 8Oropharyngeal Neoplasms 8Lung Neoplasms 6Glioblastoma 6Carcinoma, Squamous Cell 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Mouth Neoplasms 4Hypopharyngeal Neoplasms 4Esophageal Squamous Cell Carcinoma 4Colorectal Neoplasms 4Adenocarcinoma 4Radiation Injuries 3Pathologic Complete Response 3Carcinoma 3Breast Neoplasms 3Thymoma 2Resectable Esophageal Cancer 2Neoplasms 2Nasopharyngeal Neoplasms 2NSCLC 2Lymphoma 2Lymphatic Metastasis 2

Interventions

Cystectomy 2toripalimab 1tislelizumab 1liposomal doxorubicin 1disitamab vedotin 1Surgical Procedures, Operative 1Rutin 1Radiation 1RC48 antibody 1Neoadjuvant Therapy 1Gemcitabine 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Muscle Invasive Bladder Cancer × Chemoradiotherapy × Clear all
NCT02716896 2019-11-25

Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer

The University of Texas Health Science Center at San Antonio

Phase NA Terminated
2 enrolled 8 charts
Genitourinary

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡